111 related articles for article (PubMed ID: 26848078)
1. Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy.
Amioka A; Masumoto N; Gouda N; Kajitani K; Shigematsu H; Emi A; Kadoya T; Okada M
Jpn J Clin Oncol; 2016 Apr; 46(4):303-9. PubMed ID: 26848078
[TBL] [Abstract][Full Text] [Related]
2. Photoacoustic Computed Tomography of Breast Cancer in Response to Neoadjuvant Chemotherapy.
Lin L; Tong X; Hu P; Invernizzi M; Lai L; Wang LV
Adv Sci (Weinh); 2021 Apr; 8(7):2003396. PubMed ID: 33854889
[TBL] [Abstract][Full Text] [Related]
3. Effects of contrast-enhanced ultrasound treatment on neoadjuvant chemotherapy in breast cancer.
Rix A; Piepenbrock M; Flege B; von Stillfried S; Koczera P; Opacic T; Simons N; Boor P; Thoröe-Boveleth S; Deckers R; May JN; Lammers T; Schmitz G; Stickeler E; Kiessling F
Theranostics; 2021; 11(19):9557-9570. PubMed ID: 34646386
[No Abstract] [Full Text] [Related]
4. Quantitative ultrasound assessment of breast tumor response to chemotherapy using a multi-parameter approach.
Tadayyon H; Sannachi L; Gangeh M; Sadeghi-Naini A; Tran W; Trudeau ME; Pritchard K; Ghandi S; Verma S; Czarnota GJ
Oncotarget; 2016 Jul; 7(29):45094-45111. PubMed ID: 27105515
[TBL] [Abstract][Full Text] [Related]
5. Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial.
Onishi N; Li W; Gibbs J; Wilmes LJ; Nguyen A; Jones EF; Arasu V; Kornak J; Joe BN; Esserman LJ; Newitt DC; Hylton NM
Tomography; 2020 Jun; 6(2):77-85. PubMed ID: 32548283
[TBL] [Abstract][Full Text] [Related]
6. Ultrafast DCE-MRI as a new tool for treatment response prediction in neoadjuvant chemotherapy of breast cancer.
Kataoka M
Diagn Interv Imaging; 2023 Dec; 104(12):565-566. PubMed ID: 37741704
[No Abstract] [Full Text] [Related]
7. Evaluating patient-specific neoadjuvant regimens for breast cancer via a mathematical model constrained by quantitative magnetic resonance imaging data.
Jarrett AM; Hormuth DA; Wu C; Kazerouni AS; Ekrut DA; Virostko J; Sorace AG; DiCarlo JC; Kowalski J; Patt D; Goodgame B; Avery S; Yankeelov TE
Neoplasia; 2020 Dec; 22(12):820-830. PubMed ID: 33197744
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of Breast Ultrasonography and Mammography in Comparison with Postoperative Histopathology in Breast Cancer Patients after Neoadjuvant Chemotherapy.
Schmidt G; Findeklee S; Del Sol Martinez G; Georgescu MT; Gerlinger C; Nemat S; Klamminger GG; Nigdelis MP; Solomayer EF; Hamoud BH
Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685349
[TBL] [Abstract][Full Text] [Related]
9. Towards Patient-Specific Optimization of Neoadjuvant Treatment Protocols for Breast Cancer Based on Image-Guided Fluid Dynamics.
Wu C; Hormuth DA; Lorenzo G; Jarrett AM; Pineda F; Howard FM; Karczmar GS; Yankeelov TE
IEEE Trans Biomed Eng; 2022 Nov; 69(11):3334-3344. PubMed ID: 35439121
[TBL] [Abstract][Full Text] [Related]
10. Clinical Utility of Abbreviated Breast MRI to Assess Response to Neoadjuvant Chemotherapy.
Tang F; Hayward J
Radiol Imaging Cancer; 2024 Jan; 6(1):e249002. PubMed ID: 38276902
[No Abstract] [Full Text] [Related]
11. Editorial for "Effect of Physical Exercise on MRI-Assessed Brain Perfusion in Chemotherapy-Treated Breast Cancer Patients: A Randomized Controlled Trial".
Zhang Y
J Magn Reson Imaging; 2024 May; 59(5):1681-1682. PubMed ID: 37587647
[No Abstract] [Full Text] [Related]
12. Unilateral breast non-mass like metastasis from lung cancer: A case report.
Yang Q; Dong P; Chen N
Asian J Surg; 2024 Jun; ():. PubMed ID: 38845320
[No Abstract] [Full Text] [Related]
13. Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype.
Fukuda T; Horii R; Gomi N; Miyagi Y; Takahashi S; Ito Y; Akiyama F; Ohno S; Iwase T
Springerplus; 2016; 5():152. PubMed ID: 27026849
[TBL] [Abstract][Full Text] [Related]
14. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
[TBL] [Abstract][Full Text] [Related]
15. Monitoring Breast Cancer Response to Neoadjuvant Chemotherapy Using Ultrasound Strain Elastography.
Fernandes J; Sannachi L; Tran WT; Koven A; Watkins E; Hadizad F; Gandhi S; Wright F; Curpen B; El Kaffas A; Faltyn J; Sadeghi-Naini A; Czarnota G
Transl Oncol; 2019 Sep; 12(9):1177-1184. PubMed ID: 31226518
[TBL] [Abstract][Full Text] [Related]
16. Contrast-Enhanced Ultrasound for Early Prediction of Response of Breast Cancer to Neoadjuvant Chemotherapy.
Lee YJ; Kim SH; Kang BJ; Kim YJ
Ultraschall Med; 2019 Apr; 40(2):194-204. PubMed ID: 30103213
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of Contrast-Enhanced Ultrasound Compared With Magnetic Resonance Imaging in Assessing the Tumor Response After Neoadjuvant Chemotherapy for Breast Cancer.
Lee SC; Grant E; Sheth P; Garcia AA; Desai B; Ji L; Groshen S; Hwang D; Yamashita M; Hovanessian-Larsen L
J Ultrasound Med; 2017 May; 36(5):901-911. PubMed ID: 28150325
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy.
Saracco A; Szabó BK; Tánczos E; Bergh J; Hatschek T
Acta Radiol; 2017 Apr; 58(4):394-402. PubMed ID: 27461224
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of contrast-enhanced ultrasound in neoadjuvant treatment of locally advanced rectal cancer: a retrospective study.
Bai G; Wang C; Sun Y; Li J; Shi X; Zhang W; Yang Y; Yang R
Front Oncol; 2023; 13():1340060. PubMed ID: 38322290
[TBL] [Abstract][Full Text] [Related]
20. Comparison of MRI vs. [
Caracciolo M; Castello A; Urso L; Borgia F; Marzola MC; Uccelli L; Cittanti C; Bartolomei M; Castellani M; Lopci E
J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
